Our Story

New vaccine technology is changing the whole industry

 

For the past 19 years, the World Vaccine Congress Washington congress has evolved and grown into the leading vaccines congress globally, with:  350 speakers, 1500 attendees and hundreds of networking opportunities.

 

Back in 2015, we introduced a successful new format which allowed for whole-sector topics, giving an opportunity for people to find out more about their specific area of research and their job-function. By running parallel niche conferences over the 3 days, it increased the relevance of the whole event for everyone who attended.

 

In 2020, we will be continuing this format with the pre-congress workshops and conferences in:

We will also be looking to expand into newer topic areas such as BioDefense, Big Data and Bioinformatics in a greater capacity, engaging more profiles from Army, DoD, non-profits and national representatives in healthcare.

During these sessions you will learn how cutting-edge research efforts can be integrated with pharma, biotech, academia and government to produce more and better vaccines to the market.

 

With so much on show throughout these four days and unparalleled networking and learning opportunities, we’re confident that you will walk away from this year’s congress safe in the knowledge that your time has been well worth it.

 

We look forward to welcoming you there.

 

VIEW AGENDA

 
Vaccine Congress Washington event growth

WORLD VACCINE CONGRESS WASHINGTON INCLUDES:

 

INFLUENZA AND RESPIRATORY

 

Find ways to improve development of universal influenza, RSV, MERS and TB vaccines.

 

BIOPROCESSING AND MANUFACTURING

 

Optimize early formulation through to clinical manufacturing, by embracing new techniques and technologies.

 

CANCER AND IMMUNOTHERAPY

 

From new adjuvant technologies to novel immunotherapies, better understand the latest developments in the fast-evolving cancer landscape.
 

IMMUNE PROFILING

 

Discuss how profiling of the immune system using high throughput technologies can aid therapeutic design and treatment strategies in infectious and noninfectious diseases including cancer.

 

PARTNERSHIPS

 

Hear from exciting new vaccine biotechs presenting on their pipeline as well as case studies and on how best to form public-private partnerships.

CLINICAL TRIALS

 

Assess how to improve your clinical trial performance, from developing novel immunological assays to creating clinical efficacy.
 

EMERGING AND RE-EMERGING DISEASES

 

Understand the opportunities for your business in reacting to global threats like Zika, malaria, dengue and Ebola.

VETERINARY

 

From livestock to companion, gain crucial insights into the emerging infections and new technologies changing the landscape.

 

SUPPLY & LOGISTICS

 

Hear from key industry and non-profit representatives in vaccine supply, and showcase your solutions to challenges in vaccine storage, distribution, management and stock control to ensure that we achieve future global immunisation goals.

SAFETY

 

This focused vaccines safety and pharmacovigilance conference will take you through the entire life cycle of vaccine safety, from pre-clinical to post-licensure as well as covering hot topics in vaccine confidence and legislating vaccines.